Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 2, 2015, Pages 385-392

  Sinha, Neeharika ^a   Cifter, Gizem ^b,c   Sajo, Erno ^b   Phd, Rajiv Kumar ^c,d   Sridhar, Srinivas ^c,d   Nguyen, Paul L ^c   Cormack, Robert A ^c   Makrigiorgos, G Mike ^c   Ngwa, Wilfred ^b,c  

^a WENTWORTH INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DOSIMETRY; GOLD NANOPARTICLES; METAL NANOPARTICLES; ONCOLOGY; RADIATION DAMAGE; SHIMS; TUMORS; UROLOGY;

BIODISTRIBUTIONS; CONCENTRATION PROFILES; DOSE ENHANCEMENT FACTORS; DOSE ENHANCEMENTS; DOSE PAINTINGS; LOW DOSE RATE BRACHYTHERAPY; PROSTATE CANCERS; STOKES EINSTEIN EQUATIONS;

RADIOTHERAPY;

CESIUM 131; GOLD NANOPARTICLE; IODINE 125; PALLADIUM 103; DRUG IMPLANT; GOLD; METAL NANOPARTICLE;

ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY SPACER; COMPUTER MODEL; DIFFUSION COEFFICIENT; DRUG DELIVERY DEVICE; HUMAN; HUMAN CELL; LOW ENERGY RADIATION; MALE; PRIORITY JOURNAL; PROSTATE TUMOR; RADIATION DOSE; RADIATION INJURY; TUMOR CELL; TUMOR VOLUME; BIOLOGICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; DEVICES; DRUG IMPLANT; FEASIBILITY STUDY; NEOPLASMS; PROCEDURES; RADIOTHERAPY DOSAGE; THERAPEUTIC USE; TISSUE DISTRIBUTION;

BRACHYTHERAPY; COMPUTER SIMULATION; DRUG IMPLANTS; FEASIBILITY STUDIES; GOLD; HUMANS; METAL NANOPARTICLES; MODELS, BIOLOGICAL; NEOPLASMS; RADIOTHERAPY DOSAGE; TISSUE DISTRIBUTION;

EID: 84922422524     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.10.001     Document Type: Article

References (30)

1. Cho SH, La KS. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Phys Med Biol 2009;54:4889-4905.
2. Jain S, Hirst DG, O'Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 2012;85:101-113.
3. Ngwa W, Korideck H, Kassis AI, et al. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with i-125 brachytherapy seeds. Nanomedicine 2013;9:25-27.
4. Ngwa W, Kumar R, Sridhar S, et al. Targeted radiotherapy with gold nanoparticles: Current status and future perspectives. Nanomedicine (Lond) 2014;9:1063-1082.
5. Jain RK. Taming vessels to treat cancer. Sci Am 2008;298:56-63.
6. Jain RK. Delivery of molecular and cellular medicine to solid tumors. J Control Release 1998;53:49-67.
7. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010;7:653-664.
8. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: Opportunities and challenges in nanomedicine. Expert Opin Drug Deliv 2010;7:753-763.
9. Connor EE, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small (Weinheim an der Bergstrasse, Germany) 2005;1:325-327.
10. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 2010;393:649-655.
11. Shukla R, Bansal V, Chaudhary M, et al. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 2005;21:10644-10654.
12. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004;49:N309-315.
13. Nagesha DK, Tada DB, Stambaugh CK, et al. Radiosensitizer-eluting nanocoatings on gold fiducials for biological in-situ image-guided radio therapy (BIS-IGRT). Phys Med Biol 2010;55:6039-6052.
14. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 2011;3:1377-1397.
15. Wong C, Stylianopoulos T, Cui J, et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A 2011;108:2426-2431.
16. Hainfeld JF, Slatkin DN, Focella TM, et al. Gold nanoparticles: A new x-ray contrast agent. Br J Radiol 2006;79:248-253.
17. Ngwa W, Makrigiorgos GM, Berbeco RI. Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: Estimation of endothelial dose enhancement. Phys Med Biol 2010;55:6533-6548.
18. Carvalhal GF, Daudi SN, Kan D, et al. Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes. Urology 2010;76:1072-1076.
19. Eichelberger LE, Koch MO, Eble JN, et al. Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Mod Pathol 2005;18:886-890.
20. Bennewith KL, Dedhar S. Targeting hypoxic tumour cells to overcome metastasis. BMC Cancer 2011;11:504.
21. Ngwa W, Makrigiorgos GM, Berbeco RI. Gold nanoparticle-aided brachytherapy with vascular dose painting: Estimation of dose enhancement to the tumor endothelial cell nucleus. Med Phys 2012;39:392-398.
22. Berbeco RI, Ngwa W, Makrigiorgos GM. Localised dose enhancement to tumor blood vessel endothelial cells via megavoltage x-rays and targeted gold nanoparticles: New potential for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:270-276.
23. Zygmanski P, Liu B, Tsiamas P, et al. Dependence of Monte Carlo microdosimetric computations on the simulation geometry of gold nanoparticles. Phys Med Biol 2013;58:7961-7977.
24. Cole A. Absorption of 20-EV to 50, 000-EV electron beams in air and plastic. Radiat Res 1969;38:7-33.
25. Thomas DG. Transport characteristics of suspension: VIII. A note on the viscosity of Newtonian suspensions of uniform spherical particles. J Colloid Sci 1965;20.
26. Montenegro M, Nahar SN, Pradhan AK, et al. Monte Carlo simulations and atomic calculations for auger processes in biomedical nanotheranostics. J Phys Chem 2009;113:12364-12369.
27. Pradhan AK, Nahar SN, Montenegro M, et al. Resonant x-ray enhancement of the auger effect in high-z atoms, molecules, and nanoparticles: Potential biomedical applications. J Phys Chem 2009;113:12356-12363.
28. Nahar SN, Pradhan AK, Montenegro M. Resonant Theranostics: A New Nano-Biotechnological Method for Cancer Treatment Using X-Ray Spectroscopy of Nanoparticles Simulations. In: Nanobiotechnology. Boca Raton, FL: CRC Press; 2011. p. 305-330.
29. Kang B, Mackey MA, El-Sayed MA. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc 2010;132:1517-1519.
30. Kuban DA, Levy LB, Cheung MR, et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys 2011;79:1310-1317.